Regulus Therapeutics News - RGLS

Company Name	Stock Ticker Symbol	Market	Type
Regulus Therapeutics Inc	RGLS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.09	-4.05%	2.13	16:30:00

Open Price	Low Price	High Price	Close Price	Prev Close
2.23	2.09	2.31	2.13	2.22

more quote information »

Recent News

Date	Time	Source	Heading
3/21/2024	16:05	PRNUS	Regulus Therapeutics Reports Fourth Quarter and Year-End..
3/12/2024	06:32	PRNUS	Regulus Therapeutics Announces Oversubscribed $100 Million..
3/12/2024	06:30	PRNUS	Regulus Therapeutics Announces Positive Topline Data from..
1/18/2024	20:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/18/2024	20:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/12/2024	16:11	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
1/10/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/02/2024	16:05	PRNUS	Regulus Therapeutics Announces Completion of Enrollment in..
12/27/2023	16:16	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/22/2023	08:00	PRNUS	Regulus Therapeutics to Present at the 6th Annual Evercore..
11/09/2023	16:39	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:15	EDGAR2	Form 8-K - Current report
11/09/2023	16:05	PRNUS	Regulus Therapeutics Reports Third Quarter 2023 Financial..
11/02/2023	08:00	PRNUS	Regulus Therapeutics Announces First Patient Dosed in Third..
10/19/2023	08:00	PRNUS	Regulus Therapeutics Advances to Cohort 3 of Phase 1b..
9/20/2023	07:00	PRNUS	Regulus Therapeutics Announces Positive Topline Data from..
9/13/2023	08:00	PRNUS	Regulus Therapeutics Announces Completion of Enrollment in..
9/05/2023	08:00	PRNUS	Regulus Therapeutics Announces Participation at Two..
8/23/2023	08:00	PRNUS	Regulus Therapeutics to Host Virtual Investor Event on..
8/14/2023	16:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:46	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:15	EDGAR2	Form 8-K - Current report
8/08/2023	16:05	PRNUS	Regulus Therapeutics Reports Second Quarter 2023 Financial..
8/02/2023	08:00	PRNUS	Regulus Therapeutics to Present at the Canaccord Genuity..
7/18/2023	08:00	PRNUS	Regulus Therapeutics to Present at the H.C. Wainwright 2nd..
6/29/2023	16:53	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
6/27/2023	08:00	PRNUS	Regulus Therapeutics Announces First Patient Dosed in Second..
6/23/2023	08:00	PRNUS	Regulus Therapeutics Announces Appointment of Preston S...
6/20/2023	08:00	PRNUS	Regulus Therapeutics Announces Update on Preclinical Studies..
6/12/2023	08:00	PRNUS	Regulus Therapeutics Strengthens Research & Development..
5/16/2023	08:00	PRNUS	Regulus Therapeutics Advances to Cohort 2 of Phase 1b..
5/11/2023	16:05	PRNUS	Regulus Therapeutics Reports First Quarter 2023 Financial..